Molecular biomarkers and precision medicine in colorectal cancer: Value for Money?

Medicine and Dentistry

• Adoption 28%
• Analysis 28%
• Assessment 28%
• Biological Marker 100%
• Cancer 14%
• Cancer Therapy 14%
• Chemotherapy 28%
• Clinical Intervention 14%
• Clinical Support 14%
• Colorectal Cancer 100%
• Combination Therapy 42%
• Comprehension 14%
• Cost-Effectiveness Analysis 42%
• Drive 14%
• Epidermal Growth Factor Receptor 28%
• Evaluation Study 14%
• Family 14%
• Fluorouracil 14%
• Gene 42%
• Health 57%
• Health Care Cost 42%
• Health System 14%
• Inpatient 14%
• Irinotecan 28%
• Patient 57%
• Personalized Medicine 100%
• Systematic Review 14%
• Therapeutic Procedure 42%
• Toxicity 42%

Biochemistry, Genetics and Molecular Biology

• Accuracy 100%
• Comprehension 20%
• Contrast 20%
• Dihydropyrimidine Dehydrogenase 40%
• Drive 20%
• Effectiveness Study 20%
• Epidermal Growth Factor Receptor 40%
• Expression Analysis 20%
• Glucuronosyltransferase 20%
• Health 100%
• KRAS 20%
• Nested Gene 60%
• Taxonomy 20%
• Uridine 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Biological Marker 100%
• Colorectal Cancer 100%
• Dihydropyrimidine Dehydrogenase 28%
• Epidermal Growth Factor Receptor 28%
• Fluorouracil 14%
• Glucuronosyltransferase 14%
• Irinotecan 28%
• Toxicity 42%
• Uridine 14%